title: Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa-induced dyskinesia.
authors.affiliation: Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada.
authors.forename: Naomi P
authors.initials: NP
authors.lastname: Visanji
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D004409:Dyskinesia, Drug-Induced / Q000235:genetics*; D007980:Levodopa / Q000009:adverse effects*
chemical_list: D007980:Levodopa